Hi,
I have been having difficulties in monitoring CAF activation because the lung fibroblasts Wi-38 that I am using seem to already have high levels of expression of a-SMA, FAP and PDGFRb, according to my Western Blot. I am not sure if it has to do with the origin of the cells or the cell culture conditions that are activating them. Any guidance will be greatly appreciated!
The choice of whether to use adult or fetal fibroblasts for monitoring CAF (cancer-associated fibroblast) activation depends on the specific research question and experimental design.
Adult fibroblasts are derived from adult tissues, and therefore, may be more representative of the CAFs present in adult tumors. They may also be easier to obtain from patients and maintain in culture. However, adult fibroblasts may have undergone more genetic alterations and exhibit more heterogeneity than fetal fibroblasts.
On the other hand, fetal fibroblasts are derived from fetal tissues and are less exposed to environmental insults and genetic alterations than adult fibroblasts. Therefore, fetal fibroblasts may be more representative of the early stages of CAF activation. Additionally, fetal fibroblasts may exhibit less heterogeneity and have more consistent responses than adult fibroblasts.
Ultimately, the choice of which fibroblasts to use for CAF activation monitoring should be based on the specific research question and experimental design. Both adult and fetal fibroblasts can be useful tools for studying CAF activation in different contexts.
Monitoring cancer-associated fibroblast (CAF) activation can be challenging, especially when using fibroblasts derived from different sources. In general, it is believed that CAFs are primarily derived from activated resident fibroblasts in the tumor microenvironment, although some evidence suggests that they can also be derived from bone marrow-derived cells or other cell types.
When it comes to choosing between adult fibroblasts and fetal fibroblasts for monitoring CAF activation, it really depends on the type of cancer and the stage of tumor development being studied. CAFs have been shown to exhibit different phenotypes and molecular markers depending on the tumor type and stage, which can affect the choice of cell type for monitoring CAF activation.
For example, CAFs derived from adult lung fibroblasts may be more relevant for studying lung cancer, while fetal fibroblasts may be more relevant for studying embryonic or pediatric tumors. However, it's important to note that fetal fibroblasts may not accurately represent the CAFs that are present in the tumor microenvironment of adult patients.
Regarding your issue with high levels of a-SMA, FAP, and PDGFRb expression in the Wi-38 cells you are using, it's possible that the culture conditions are contributing to the activation of these cells. Fibroblasts can become activated in response to various stimuli, including growth factors, extracellular matrix components, and mechanical stress. Therefore, it may be helpful to review the culture conditions you are using and adjust them as needed to minimize the activation of your cells.
In addition to Western blot analysis, there are other techniques available for monitoring CAF activation, including immunofluorescence staining, qPCR, and functional assays such as migration and invasion assays. It may be helpful to use a combination of these techniques to gain a more complete understanding of CAF activation in your experimental system.
- Badges
- Science topic
- Similar topics
- Chemistry
- Pharmacology
- Medical Pharmacology
- Clinical Pharmacology